• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate
Neohesperidin
Advantame
Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench
Pharma and Food Grade, USP/FCC Neotame Sweetener E961
Trilobatin

Venezuela receives first shipment of Cuban coronavirus vaccine

firstwordpharmaJune 25, 2021

Tag: Venezuela , Cuban coronavirus , Vaccine

Venezuela’s vice president Delcy Rodriguez said the country received its first shipment of doses of Cuba's Abdala COVID-19 vaccine on Thursday, as reported in This is Money.

Venezuela receives first shipment of Cuban coronavirus vaccine

Authorities did not specify how many doses had arrived, but said that Venezuela had signed a contract to purchase 12 million doses of the vaccine. 

Earlier this week, Cuba said that the three-shot Abdala vaccine had proved 92.28% effective in last-stage clinical trials.

Since February, Venezuela has received some 3.5 million doses of Russian and Chinese vaccines for its population of approximately 28 million. 


Previous:OncoSec Appoints Brian Leuthner as Interim CEO

Next:Hospital Factors Tied to Greater COVID-19 Mortality in Blacks

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

Venezuela receives first shipment of Cuban coronavirus vaccine | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

Ruminant Vaccine Series

Ruminant Vaccine Series
Eurping GMP Washing and Drying Instrument Applied to Pharmaceutical and Vaccine Production

Eurping GMP Washing and Drying Instrument Applied to Pharmaceutical and Vaccine Production
2019-nCoV Vaccine(Vero Cells),Inactivated

2019-nCoV Vaccine(Vero Cells),Inactivated
Rabies Vaccine(Vero Cell)for Human use

Rabies Vaccine(Vero Cell)for Human use
Swine Vaccine Series

Swine Vaccine Series
Haemophilus Influenza Type B Conjugate Vaccine

Haemophilus Influenza Type B Conjugate Vaccine
Vi Polysaccharide Typhoid Vaccine

Vi Polysaccharide Typhoid Vaccine
DTaP-Hib combined Vaccine

DTaP-Hib combined Vaccine
Poliomyelitis Vaccine Type I Type III in Dragee Candy (Human Diploid Cell), Live

Poliomyelitis Vaccine Type I Type III in Dragee Candy (Human Diploid Cell), Live
Group A and C Meningococcal+Haemophilus Type B Conjugate Vaccine

Group A and C Meningococcal+Haemophilus Type B Conjugate Vaccine

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service